Targeted ErbB3 cancer therapy: A synergistic approach to effectively combat cancer-Reference-Cited by-同舟云学术

Targeted ErbB3 cancer therapy: A synergistic approach to effectively combat cancer

Published:2020-02 Issue: Volume:575 Page:118961
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Ali Muhammad Yasir,Tariq Imran,Ali Sajid,Amin Muhammad Umair,Engelhardt Konrad,Pinnapireddy Shashank Reddy^ORCID,Duse Lili,Schäfer Jens,Bakowsky Udo^ORCID

Funder

University of the Punjab, Pakistan

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference40 articles.

1. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo;Farokhzad;Proc. Natl. Acad. Sci.,2006

2. Aptamer-labeled PLGA nanoparticles for targeting cancer cells;Aravind;Cancer Nanotechnol.,2012

3. Targeted nanomedicines: effective treatment modalities for cancer;Muthu;AIDS Brain Disorders,2009

4. Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents;Dinarvand;Int. J. Nanomed.,2011

5. Aptamer-based liposomes improve specific drug loading and release;Plourde;J. Control. Release,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of peptides, aptamers, and variable domains of heavy chain only antibodies in tissue engineering and regenerative medicine;Acta Biomaterialia;2023-10

2. Aptamer-functionalized PLGA nanoparticles for targeted cancer therapy;Aptamers Engineered Nanocarriers for Cancer Therapy;2023

3. Co-delivery of carbonic anhydrase IX inhibitor and doxorubicin as a promising approach to address hypoxia-induced chemoresistance;Drug Delivery;2022-07-17

4. Ultrasound-Responsive Smart Drug Delivery System of Lipid Coated Mesoporous Silica Nanoparticles;Pharmaceutics;2021-09-03

5. Enhanced efficacy and drug delivery with lipid coated mesoporous silica nanoparticles in cancer therapy;European Journal of Pharmaceutics and Biopharmaceutics;2021-08